2-Benzylidene-4-methyl-3-oxo-N-phenylpentanamide, 95.0%, 5g

N-(6-Oxo-6,9-dihydro-1H-purin-2-yl)acetamide, 97.0%, 25g

6,8-Difluoro-3,4-dihydronaphthalen-2(1H)-one, 95.0%, 10g

2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-8-(tert-butoxycarbonyl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid, 97%, 5g

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 100 ml, glass packaging

4'-Hydroxybiphenyl-4-carboxamidoxime, 5g

6-Trifluoromethyl-2,3-dihydro-1H-quinazolin-4-one, 97%, 100mg

(S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methoxy-5-oxopentanoic acid, 95.0%, 25g

ETHYL 5-BROMO-1H-IMIDAZOLE-4-CARBOXYLATE, 95.0%, 1g

Boc-D-Ala-OSu, 95.0%, 5g

Thioacetic Acid>95.0%(GC)500mL

2-(1H-1,2,4-Triazol-1-yl)benzene-1,3,5-tricarboxylic acid, 98%, 250mg

4-(Trifluoromethyl)cyclohexanemethanol (cis- and trans- mixture)>98.0%(GC)1g